Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
05/2003
05/08/2003US20030086969 Ciprofoxacin-metronidazole antibiotic composition
05/08/2003US20030086965 Combination chemotherapy
05/08/2003US20030086933 Therapeutic systems
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086916 Administering to the animal a therapeutically effective amount of an agent which is selected from the group consisting of premature vascular senescence ameliorating ebselen-class compounds for therapy of premature vascular senescence
05/08/2003US20030086901 Combination therapies using vitamin B12 and interferon for treatment of viral, proliferative and inflammatory diseases
05/08/2003US20030086900 Method of treatment using ligand-immunogen conjugates
05/08/2003US20030086881 Antiinfective combinations and their use for the topical treatment of fungal infections of the toenails and fingernails
05/08/2003US20030084912 Composition to reduce or quit smoking addiction
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2466424A1 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003CA2465682A1 Methods of treating leukemia
05/08/2003CA2465632A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003CA2465429A1 Compounds and method for the treatment of overactive bladder
05/08/2003CA2465382A1 Indole compound and medicinal use thereof
05/08/2003CA2465316A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents
05/08/2003CA2465188A1 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
05/08/2003CA2465140A1 Method for the treatment of overactive bladder
05/08/2003CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
05/08/2003CA2464889A1 Cytokine-inducing material and cytokine-inducing instrument
05/08/2003CA2464656A1 Spray drying methods and compositions thereof
05/08/2003CA2464479A1 Methods and formulations for minimizing spasticity in blood vessel grafts
05/08/2003CA2463580A1 Polymer conjugates of protein kinase c inhibitors
05/08/2003CA2462660A1 Nucleic acid-associated proteins
05/08/2003CA2462525A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003CA2460118A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/08/2003CA2451168A1 Methods for assessing and treating leukemia
05/08/2003CA2450726A1 Cream for treating photoinduced skin damage comprising lipoic acid, coenzyme q-10 and acetyl-l-carnitine
05/07/2003EP1308457A1 Ribosome structure and protein synthesis inhibitors
05/07/2003EP1308448A1 Method for the preparation of chromanone
05/07/2003EP1308155A2 Injectable solution containing a colloid of iron and shark cartilage-derived chondroitin sulfate
05/07/2003EP1307748A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors
05/07/2003EP1307746A1 Identification of viral agents in breast ducts and antiviral therapy therefore
05/07/2003EP1307594A1 Association of sim2 with cancer
05/07/2003EP1307588A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307539A2 Gene expression profile for kshv infection and methods for treating same
05/07/2003EP1307486A2 Somatostatin analogues
05/07/2003EP1307481A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression
05/07/2003EP1307454A1 Derivatives of variolin b
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307264A2 New pharmaceutical composition
05/07/2003EP1307263A2 New use of lipase inhibitors
05/07/2003EP1307262A1 Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity
05/07/2003EP1307245A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
05/07/2003EP1307243A2 A medicinal aerosol formulation
05/07/2003EP1307232A1 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307227A2 Pharmaceutical compositions
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307225A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307209A1 Cardioplegic solution
05/07/2003EP1307208A1 Use of co for treating inflammation of upper airways or bronchi
05/07/2003EP1307202A1 Method for the treatment of overactive bladder
05/07/2003EP1307201A2 Selective pde 2 inhibitors, used as medicaments for improving cognition
05/07/2003EP1307199A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation
05/07/2003EP1307197A2 Compositions for the treatment of cancer comprising a topoisomerase inhibitor and thalidomide
05/07/2003EP1307196A1 Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
05/07/2003EP1307195A2 Medicaments containing cilansetron for treating non-obstipated male ibs patients
05/07/2003EP1307191A2 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure
05/07/2003EP1307190A1 Use of il-8 receptor antagonists in the treatment of virus infections
05/07/2003EP1307189A2 Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
05/07/2003EP1307183A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
05/07/2003EP1307108A2 Oil/fat composition
05/07/2003EP1307107A2 Oil/fat composition
05/07/2003EP1263447A4 Optically-active nanoparticles for use in therapeutic and diagnostic methods
05/07/2003EP1216043B1 Retard form containing alpha-lipoic acid (derivatives)
05/07/2003EP1143996B1 Use of a bpi protein for the preparation of a medicament for treating chronic cardiac disease
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP1061963B1 Protease inhibitors in absorbent articles
05/07/2003EP1054681B1 The use of combinations of active agents consisting of antibiotics and plant extracts containing terpene in veterinary medicine
05/07/2003EP1032414B1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/07/2003EP1019055B1 Endothelin antagonist and beta receptor blocking agent as combined preparations
05/07/2003EP1019023B1 Stabilized preparations for use in nebulizers
05/07/2003EP0959876B1 Method for separating active substances in solid pharmaceutical preparations
05/07/2003EP0889880B1 Eprosartan dihydrate and a process for its production and formulation
05/07/2003EP0812184B1 Nitric oxide synthase inhibitors
05/07/2003EP0742720B1 Co-administration of interleukin-3 mutant polypeptides with csf's for multi-lineage hematopoietic cell production
05/07/2003EP0665729B1 Biocompatible polymers containing diagnostic or therapeutic moieties
05/07/2003EP0627940B1 Use of immunoconjugates for the diagnosis and/or therapy of vascularized tumors
05/07/2003CN1416425A 1,5-bemzothiazepines and their use as hypolipidaemics
05/07/2003CN1416411A Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416353A Anti-infective active substance combinations and use thereof for topical treatment of fungus diseases of toe and finger nails
05/07/2003CN1416344A Novel wse of (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylamino methyl]-chromane and its physiologically acceptable salts
05/07/2003CN1416340A Compsns for delivery of contisol antagonist
05/07/2003CN1416335A New self emulsifying drug delivery system
05/07/2003CN1107505C Synergistic combination of AIDS antiviral compounds and HIV inhibitor
05/07/2003CN1107499C Nitric oxide donor compsns. and method for treating anal disorders
05/06/2003USRE38115 Treating chronic or intractable pain, for treating tinnitus and for treating sexual dysfunction
05/06/2003US6559295 Mycobacterium fol A gene that encodes for the enzyme dihydrofolate reductase
05/06/2003US6559289 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia
05/06/2003US6559189 Non-toxic antimicrobial compositions and methods of use
05/06/2003US6559187 For treating hyperglycemia and diabetes
05/06/2003US6559184 Methods and compositions for treating male erectile dysfunction
05/06/2003US6559176 A method for regulating the activity of an autoinducer-2 receptor comprising contacting an autoinducer-2 receptor with an AI-2 agonist or antagonist compound.
05/06/2003US6559154 Composition of sodium channel blocking compound
1 ... 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 ... 1151